Pirenoxine

Jump to navigation Jump to search
Pirenoxine
Clinical data
Trade namesCatalin
ATCvet code
Identifiers
CAS Number
PubChem CID
ChemSpider
UNII
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC16H8N2O5
Molar mass308.24512 g/mol
3D model (JSmol)

WikiDoc Resources for Pirenoxine

Articles

Most recent articles on Pirenoxine

Most cited articles on Pirenoxine

Review articles on Pirenoxine

Articles on Pirenoxine in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Pirenoxine

Images of Pirenoxine

Photos of Pirenoxine

Podcasts & MP3s on Pirenoxine

Videos on Pirenoxine

Evidence Based Medicine

Cochrane Collaboration on Pirenoxine

Bandolier on Pirenoxine

TRIP on Pirenoxine

Clinical Trials

Ongoing Trials on Pirenoxine at Clinical Trials.gov

Trial results on Pirenoxine

Clinical Trials on Pirenoxine at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Pirenoxine

NICE Guidance on Pirenoxine

NHS PRODIGY Guidance

FDA on Pirenoxine

CDC on Pirenoxine

Books

Books on Pirenoxine

News

Pirenoxine in the news

Be alerted to news on Pirenoxine

News trends on Pirenoxine

Commentary

Blogs on Pirenoxine

Definitions

Definitions of Pirenoxine

Patient Resources / Community

Patient resources on Pirenoxine

Discussion groups on Pirenoxine

Patient Handouts on Pirenoxine

Directions to Hospitals Treating Pirenoxine

Risk calculators and risk factors for Pirenoxine

Healthcare Provider Resources

Symptoms of Pirenoxine

Causes & Risk Factors for Pirenoxine

Diagnostic studies for Pirenoxine

Treatment of Pirenoxine

Continuing Medical Education (CME)

CME Programs on Pirenoxine

International

Pirenoxine en Espanol

Pirenoxine en Francais

Business

Pirenoxine in the Marketplace

Patents on Pirenoxine

Experimental / Informatics

List of terms related to Pirenoxine

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Overview

Pirenoxine (abbreviated PRX, trade name Catalin) is a medication used in the possible treatment and prevention of cataracts. A report in the journal of Inorganic Chemistry showed that in liquid solutions pirenoxine could cause decreased cloudiness of a crystallin solution produced to mimic the environment of the eye. Pirenoxine interacts with selenite or calcium ions that have been proven as factors leading to the formation of lens cataract. Pirenoxine reduces the cloudiness of the lens solution containing calcium by 38% and reduced the cloudiness of the selenite solution by 11%.

References